Company intelligence / Profile preview

Phase I Clinical Study Institute

Cypress, California, United States

Ownership: Private
Development stage: Other

Overview

Phase I Clinical Study Institute (PCSI) is a contract research organization (CRO) and clinical research site based in the United States. The institute specializes in conducting Phase I and Phase II clinical trials, providing comprehensive services for pharmaceutical and biotechnology companies. PCSI offers a range of clinical research capabilities, including study design, recruitment, and data management, with a focus on early-phase safety and efficacy evaluations. The facility is equipped to handle complex protocols and provides a controlled environment for monitoring study participants.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Phase I Clinical Study Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phase I Clinical Study Institute.

Explore the full profile